Epidemiology of hip and knee pain and its impact on overall health status in older adults.
Dawson J, Linsell L, Zondervan K, Rose P, Randall T, Carr A. Rheumatology (Oxford) 2004;43(4):497–504. [PubMed] [Google Scholar]

OARSI recommendations for the management of hip and knee osteoarthritis, Part II:
hang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N.OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162. [PubMed]

Recommendations for the treatment of knee osteoarthritis, using various therapy techniques, based on categorizations of a literature review.
Thomas A, Eichenberger G, Kempton C, Pape D, York S, Decker AM. J Geriatr Phys Ther. 2009;32(1):33–38. [PubMed]

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.
Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK. Osteoarthritis Cartilage. 2010;18(4):476–499. [PubMed]

Advances in insoles and shoes for knee osteoarthritis.
Hinman RS, Bennell KL. Curr Opin Rheumatol. 2009;21(2):164–170. [PubMed]

Clinical practice guidelines for rest orthosis, knee sleeves, and unloading knee braces in knee osteoarthritis.
 Beaudreuil J, Bendaya S, Faucher M, Coudeyre E, Ribinik P, Revel M.Joint Bone Spine. 2009;76(6):629–636. [PubMed]

Mind-Body Therapies and Osteoarthritis of the Knee.
Selfe TK, Innes KE. Curr Rheumatol Rev. 2009;5(4):204–211. [PMC free article] [PubMed]

The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies.
Hepper CT, Halvorson JJ, Duncan ST, Gregory AJ, Dunn WR, Spindler KP. J Am Acad Orthop Surg. 2009;17(10):638–646. [PubMed]

Viscosupplementation for the treatment of osteoarthritis of the knee.
Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Cochrane Database Syst Rev. 2006;(2) CD005321. [PubMed]

Viscosupplementation for knee osteoarthritis: a systematic review.
Divine JG, Zazulak BT, Hewett TE.Clin Orthop Relat Res. 2007;455:113–122. [PubMed]

The Polysaccharides.
ransson L. Mammalian Glycosaminoglycans. In: Aspinall G, Academic Press, Inc.; St Louis, Missouri, USA: 1985. pp. 337–351.

Chemical structure of hyaluronic acid. Fed Proc.
Meyer K. 1958;17(4):1075–1077. [PubMed]

Comparative study of hyaluronic derivatives: rheological behavior.
Prieto JG, Pulido MM, Zapico J, Molina AJ, Gimeno M, Coronel P.mechanical and chemical degradation. Int J Biol Macromol. 2005;35(1-2):43–49. [PubMed]

High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. Osteoarthritis Cartilage. 2006;14(12):1237–1247. [PubMed]

The in vitro effect of hyaluronic acid on Il-1ß production in cultured rheumatoid synovial cells.
Takeshita S, Mizuno S, Kikuchi T, Yamada H, Nakimi O, Kumagai K. Biomed Res. 1997;18(3):187–194.

Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints.
Pathol Biol (Paris) 1974;22(8):731–736. Peyron JG, Balazs EA. [PubMed]

Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.

Bagga H, Burkhardt D, Sambrook P, March L. J Rheumatol. 2006;33(5):946–950. [PubMed]

Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages.
Yasuda T.Tohoku J Exp Med. 2010;220(3):229–235. [PubMed]

Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells.
Sasaki A, Sasaki K, Konttinen YT, Santavirta S, Takahara M, Takei HTohoku J Exp Med. 2004;204(2):99–107. [PubMed]

The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment.
Smith MM, Ghosh P. Rheumatol Int. 1987;7(3):113–122. [PubMed]

 Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents.
Arthritis Rheum. Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C. 2004;50(1):314–326. [PubMed]

Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the guinea pig.omis A, Miralles A, Schmidt RF, Belmonte C. Osteoarthritis Cartilage. 2009;17(6):798–804. [PubMed]

Effects of hyaluronic acid on the release of cartilage matrix proteoglycan and fibronectin from the cell matrix layer of chondrocyte cultures: interactions between hyaluronic acid and chondroitin sulfate glycosaminoglycan.
Kato Y, Mukudai Y, Okimura A, Shimazu A, Nakamura S.J Rheumatol Suppl. 1995;43:158–159. [PubMed]

Effects of hyaluronic acid on the morphology and proliferation of human chondrocytes in primary cell culture.
Ehlers EM, Behrens P, Wunsch L, Kuhnel W, Russlies M.Ann Anat. 2001;183(1):13–17. [PubMed]

Intra articular injections of Hylan GF-20 reduce type 2 collagen degradation in patients with knee osteoarthritis: the biovisco study.
Conrozier T, Walliser-Lohse A, Richette P. Ann Rheum Dis. 2010;69(Suppl 3):281.

Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee.
Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B. Osteoarthritis Cartilage. 1997;5(3):153–160. [PubMed]

Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee.
Guidolin DD, Ronchetti IP, Lini E, Guerra D, Frizziero L. Osteoarthritis Cartilage. 2001;9(4):371–381. [PubMed]

A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee.
Jubb RW, Piva S, Beinat L, Dacre J, Gishen P.Int J Clin Pract. 2003;57(6):467–474. [PubMed]

 Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: the MESSAGE study.
Mazières B, Bard H, Ligier M, Bru I, d’Orsay GG, Le Pen C. Joint Bone Spine. 2007;74(5):453–460. [PubMed]

Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis.
Waddell DD, Bricker DC. J Manag Care Pharm. 2007;13(2):113–121. [PubMed]

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.
Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA. Osteoarthritis Cartilage. 2002;10(7):518–527. [PubMed]

Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution.
Milas M, Rinaudo M, Roure I, Al-Assaf S, Phillips GO, Williams PA. Biopolymers. 2001;59(4):191–204. [PubMed]

Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?
Ghosh P, Guidolin D.Semin Arthritis Rheum. 2002;32(1):10–37. [PubMed]

Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?
Conrozier T, Vignon E. Clin Exp Rheumatol. 2005;23(5):711–716. [PubMed]

Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder.
Itokazu M, Matsunaga T.Clin Ther. 1995;17(5):946–955. [PubMed]

Intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.
Ann Rheum Dis.  Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL. Single,2010;69(1):113–119. [PMC free article] [PubMed]

Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis-meta-analysis.
Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon Osteoarthritis Cartilage. 2011;19(6):611–619. [PubMed]

Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol.
Brown TJ, Laurent UB, Fraser JR. 1991;76(1):125–134. [PubMed]

 Intra-articular sodium hyaluronate injections after arthroscopic debridement for osteoarthritis of the knee: a prospective, randomized, controlled study.
Heybeli N, Doral MN, Atay OA, Leblebicioglu G, Uzümcügil A. Acta Orthop Traumatol Turc. 2008;42(4):221–227. [PubMed]

Intra-articular hyaluronic acid after knee arthroscopy: a two-year study.
Knee Surg Sports Traumatol Arthrosc. 2007;15(5):537–546.  Hempfling H. [PubMed]

 Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials.
Bjordal JM, Klovning A, Ljunggren AE, Slørdal L.Eur J Pain. 2007;11(2):125–138. [PubMed]

Evaluation of the effect of adding corticosteroid to viscosupplementation: a prospective and randomized study. In: Campos GC, Rezende MU, Pailo AF, Pasqualim T, Camargo OP. World Congress on Osteoarthritis, San Diego, CA, 2011.

Acetaminophen for osteoarthritis.
Cochrane Database Syst Rev. 2006 Jan 25;(1) CD004257. Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. [PMC free article] [PubMed]

Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone.
Vad VB, Bhat AL, Sculco TP, Wickiewicz TL. Arch Phys MedRehabil. 2003;84(5):634–637. [PubMed]

Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F, Gebhardt U, Meng T, Murray C.  Curr Med Res Opin. 2005;21(8):1261–1269. [PubMed]